1. Home
  2. IPO
  • Blue Jet Healthcare Ltd Ipo
77761
Off
Blue Jet Healthcare IPO

Blue Jet Healthcare IPO

  • Status: Closed
  • RHP:
  • ₹ 14,147 / 43 shares

    Minimum Investment

IPO Details

  • Open Date

    25 Oct 2023

  • Close Date

    27 Oct 2023

  • IPO Price Range

    ₹ 329 to ₹346

  • IPO Size

    ₹ 840.27 Cr

  • Listing Exchange

    BSE, NSE

  • Listing Date

    06 Nov 2023

With just a few clicks, Invest in IPOs!

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Objective Financials SWOT FAQ Contacts

IPO Timeline

Blue Jet Healthcare IPO Subscription Status

Last Updated: 03 November 2023 12:25 PM by 5Paisa

Blue Jet Healthcare Limited IPO is all set to open from 25th October to 27th October 2023. The company is engaged in the business of pharmaceutical and healthcare ingredients. The IPO includes an Offer for Sale (OFS) of 24,285,160 equity shares worth ₹840.27 cr. There is no fresh issue of shares. The share allotment date is 1st November, and the IPO will be listed on 6th November on the stock exchanges. The price band is ₹329 to ₹346 per share and the lot size is 43 shares.    

Kotak Mahindra Capital Company Limited, ICICI Securities Limited, and J.P. Morgan India Private Limited are the book-running lead managers for this IPO, while Link Intime India Private Limited is the registrar. 

Objectives of Blue Jet Healthcare IPO:

The company will not receive any proceeds from the Offer. The entire Offer Proceeds will be received by the Selling Shareholders.
 

Blue Jet Healthcare IPO Video:

 

Established in 1968, Blue Jet Healthcare Limited is one of the prominent pharmaceutical and healthcare ingredients as well as an intermediary company in the country. Blue Jet Healthcare is also renowned for being the first company to introduce saccharin and its salts (artificial sweeteners) in India. Later, the company expanded its expertise to include contrast media intermediates, which are crucial components for CT scans and MRIs. 

The company's primary focus revolves around three product categories: i) contrast media intermediates ii) high-intensity sweeteners iii) pharmaceutical intermediates, including active pharmaceutical ingredients.

Blue Jet Healthcare is a global pharmaceutical company driven by scientific innovation. The company provides services related to

●    Global regulatory support
●    Process development and production capabilities
●    Collaboration, development, and production of advanced pharmaceutical intermediates and APIs

To meet the growing demand, Blue Jet Healthcare operates three manufacturing facilities, strategically positioned in Shahad (Unit I), Ambernath (Unit II), and Mahad (Unit III) within the state of Maharashtra, India. As of June 30, 2023, these facilities have impressive annual installed capacities of 200.60 KL, 607.30 KL, and 213.00 KL, respectively.

Peer Comparison
There are no listed peers in India engaged in a similar business.

For More Information:
Webstory on Blue Jet Healthcare IPO

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY22 FY21
Revenue 720.98 683.47 498.93
EBITDA 219.08 249.26 206.05
PAT 160.02 181.59 135.79
Particulars (in Rs. Crores) FY23 FY22 FY21
Total Assets 862.06 713.37 536.27
Share Capital 34.69 34.69 9.91
Total Borrowings 180.58 191.83 196.45
Particulars (in Rs. Crores) FY23 FY22 FY21
Net cash generated from / (used in) operating activities 141.56 146.41 129.27
Net cash from / (used in) investing activities -147.25 -76.02 -50.72
Net cash flow from / (used in) financing activities -4.24 -56.14 -27.49
Net increase (decrease) in cash and cash equivalents -9.93 14.24 51.05


Strengths

1.    The company is a large manufacturer of contrast media intermediates in India.
2.    Presence in niche categories with high barriers to entry.
3.    Long-standing relationships and multi-year contracts with multinational customers.
4.    Strong product development and process optimization capabilities with a focus on sustainability.
5.    Manufacturing facilities with regulatory accreditations.
6.    Experienced management team with proven execution capabilities.
 

Risks

1.    Significant working capital requirements. 
2.    Heavily reliant on Europe and the United States, which are regulated markets, for a significant portion of revenue from operations.
3.    Exposed to counterparty credit risk and foreign exchange risk. 
4.    Subject to extensive government regulations.
5.    Pricing pressure from customers may affect the gross margin, profitability and ability to increase prices.
6.    The company is entitled to certain incentive schemes for exports. Any decrease in or discontinuation of such schemes may affect the results of operations.
 

Will You Apply for Blue Jet Healthcare IPO?

Yes No Maybe
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

The minimum lot size of Blue Jet Healthcare IPO is 43 shares and the investment required is ₹14,147.

The price band of Blue Jet Healthcare IPO is ₹329 to ₹346.

Blue Jet Healthcare IPO is open from 25th October to 27th October 2023.
 

The size of Blue Jet Healthcare IPO is ₹840.27, which includes an Offer for Sale (OFS) of 24,285,160 equity shares. 

The share allotment date of Blue Jet Healthcare IPO is 1st of November 2023.

The Blue Jet Healthcare IPO will be listed on the 6th of November 2023.

Kotak Mahindra Capital Company Limited, ICICI Securities Limited, and J.P. Morgan India Private Limited are the book-running lead managers for Blue Jet Healthcare IPO.

Blue Jet Healthcare will not receive any proceeds from the Offer. The entire Offer Proceeds will be received by the Selling Shareholders.
 

To apply for Blue Jet Healthcare IPO, follow the steps given below:

●    Login to your 5paisa account and select the issue in the current IPO section    
●    Enter the number of lots and the price at which you wish to apply for the Blue Jet Healthcare IPO.    
●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.    
●    You will receive a mandate notification to block funds in your UPI app.